April 2022 Publications
- Accelerating research and development of new vaccines against tuberculosis: a global roadmap. Cobelens F, Suri RK, Helinski M, Makanga M, Weinberg AL, Schaffmeister B, Deege F, Hatherill M; TB Vaccine Roadmap Stakeholder Group. Lancet Infect Dis. 2022 Apr. doi: 10.1016/S1473-3099(21)00810-0. Epub 2022 Feb 28.
- BCG vaccination induces cross-protective immunity against pathogenic microorganisms. Soto JA, Gálvez NMS, Andrade CA, Ramírez MA, Riedel CA, Kalergis AM, Bueno SM. Trends Immunol. 2022 Apr. doi: 10.1016/j.it.2021.12.006. Epub 2022 Jan 22.
- Ethical considerations in international clinical trial site selection. Miller J, Millum J. BMJ Glob Health. 2022 Apr. doi: 10.1136/bmjgh-2021-008012.
- Preclinical Safety Evaluation: Acute and Repeated-Dose Toxicity of a New Intranasal Recombinant Vector Vaccine TB/FLU-04L Against Tuberculosis. Stosman K, Sivak K, Aleksandrov A, Buzitskaya Z, Rassokha T, Stukova M. Drug Res (Stuttg). 2022 Apr. doi: 10.1055/a-1771-5985. Epub 2022 Apr 6.
- Comparison of Cytokines Expression from Human Monocyte-Derived Macrophages Infected with Different Species of Mycobacteria. Madhvi A, Mishra H, Chegou NN, Mkhonza MN, Ndou S, Tromp G, Baker B. J Interferon Cytokine Res. 2022 Apr. doi: 10.1089/jir.2021.0216. Epub 2022 Feb 14.
- Bacillus Calmette-Guérin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: A Post Hoc Analysis of a Randomized Controlled Trial. Pittet LF, Fritschi N, Tebruegge M, Dutta B, Donath S, Messina NL, Casalaz D, Hanekom WA, Britton WJ, Robins-Browne R, Curtis N, Ritz N. Am J Respir Crit Care Med. 2022 Apr 1. doi: 10.1164/rccm.202108-1892OC.
- Whole blood GBP5 protein levels in patients with and without active tuberculosis. Yao X, Liu W, Li X, Deng C, Li T, Zhong Z, Chen S, Ge Z, Zhang X, Zhang S, Wang Y, Liu Y, Zheng C, Ge S, Xia N. BMC Infect Dis. 2022 Apr 3. doi: 10.1186/s12879-022-07214-8.
- Simulating partial vaccine protection: BCG in badgers. Smith GC, Barber A, Breslin P, Birch C, Chambers M, Dave D, Hogarth P, Gormley E, Lesellier S, Balseiro A, Budgey R. Prev Vet Med. 2022 Apr 1. doi: 10.1016/j.prevetmed.2022.105635. Online ahead of print.
- Role of antibodies in vaccine-mediated protection against tuberculosis. Dieli F, Ivanyi J. Cell Mol Immunol. 2022 Apr 8. doi: 10.1038/s41423-022-00861-6. Online ahead of print.
- Structural and functional characterization of a hypothetical protein in the RD7 region in clinical isolates of Mycobacterium tuberculosis – an in silico approach to candidate vaccines. Kootery KP, Sarojini S. J Genet Eng Biotechnol. 2022 Apr 8. doi: 10.1186/s43141-022-00340-5.
- Host transcriptomic signatures of tuberculosis can predict immune reconstitution inflammatory syndrome in HIV patients. Mbandi SK, Painter H, Penn-Nicholson A, Toefy A, Erasmus M, Hanekom WA, Scriba TJ, Lai RPJ, Marais S, Fletcher HA, Meintjes G, Wilkinson RJ, Cotton MF, Pahwa S, Cameron MJ, Nemes E. Eur J Immunol. 2022 Apr 9. doi: 10.1002/eji.202249815. Online ahead of print.
- Tuberculosis vaccines in the era of Covid-19 – what is taking us so long? Dockrell HM, McShane H. EBioMedicine. 2022 Apr 12. doi: 10.1016/j.ebiom.2022.103993. Online ahead of print.
- Effectiveness of Bacillus Calmette-Guérin vaccination against severe childhood tuberculosis in China: a case-based, multicenter retrospective study. Liao Q, Zheng Y, Wang Y, Ye L, Liu X, Jiao W, Liu Y, Zhu Y, Jia J, Sun L, Shen A, Wan C. Int J Infect Dis. 2022 Apr 13. doi: 10.1016/j.ijid.2022.04.023. Online ahead of print.
- Mycobacterium bovis Wild-Type BCG or Recombinant BCG Secreting Murine IL-18 (rBCG/IL-18) Strains in Driving Immune Responses in Immunocompetent or Immunosuppressed Mice. Fol M, Włodarczyk M, Kowalewicz-Kulbat M, Druszczyńska M, Krawczyk KT, Wawrocki S, Rudnicka W, Chmiela M. Vaccines (Basel). 2022 Apr 14. doi: 10.3390/vaccines10040615.
- Cascade Immune Mechanisms of Protection against Mycobacterium tuberculosis (IMPAc-TB): study protocol for the Household Contact Study in the Western Cape, South Africa. Hiemstra AM, MacDonald CE, van Rensburg IC, Stanley K, Maasdorp E, Mc Anda S, Tönsing S, Shaw JA, Tromp G, van der Spuy GD, Urdahl KB, Lewinsohn DM, Kuivaniemi H, Du Plessis N, Malherbe ST, Walzl G. BMC Infect Dis. 2022 Apr 15. doi: 10.1186/s12879-022-07349-8.
- Chitosan nanoparticles containing fusion protein (Hspx-PPE44-EsxV) and resiquimod adjuvant (HPERC) as a novel booster vaccine for Mycobacterium tuberculosis. Hoseinpur R, Hasani A, Baradaran B, Abdolalizadeh J, Amini Y, Salehi R, Samadi Kafil H, Azizian K, Memar MY, Gholizadeh P, Hasani A. J Biomater Appl. 2022 Apr 17. doi: 10.1177/08853282221079105. Online ahead of print.
- Multiplexed Strain Phenotyping Defines Consequences of Genetic Diversity in Mycobacterium tuberculosis for Infection and Vaccination Outcomes. Carey AF, Wang X, Cicchetti N, Spaulding CN, Liu Q, Hopkins F, Brown J, Sixsmith J, Sutiwisesak R, Behar SM, Ioerger TR, Fortune SM. mSystems. 2022 Apr 18. doi: 10.1128/msystems.00110-22. Online ahead of print.
- Mycobacterium tuberculosis EspK Has Active but Distinct Roles in the Secretion of EsxA and EspB. Lim ZL, Drever K, Dhar N, Cole ST, Chen JM. J Bacteriol. 2022 Apr 19. doi: 10.1128/jb.00060-22. Epub 2022 Mar 22.
- Drug resistant tuberculosis: Current scenario and impending challenges. Singh Dewhare S. Indian J Tuberc. 2022 Apr. doi: 10.1016/j.ijtb.2021.04.008. Epub 2021 Apr 20.
- Updating age-specific contact structures to match evolving demography in a dynamic mathematical model of tuberculosis vaccination. Weerasuriya CK, Harris RC, McQuaid CF, Gomez GB, White RG. PLoS Comput Biol. 2022 Apr 22. doi: 10.1371/journal.pcbi.1010002. Online ahead of print.
- A century of attempts to develop an effective tuberculosis vaccine: Why they failed? Soleimanpour S, Yaghoubi A, Sadat Seddighinia F, Rezaee SAR. Int Immunopharmacol. 2022 Apr 26. doi: 10.1016/j.intimp.2022.108791. Online ahead of print.
- Molecular characterization of Mycobacterium tuberculosis through MPT64 gene polymorphism using next-generation sequencing technology. Zamir H, Ahmad B, Ali S, Khan SA, Sarwar R, Khan A, Ali J, Khan AA. Future Microbiol. 2022 Apr 27. doi: 10.2217/fmb-2020-0231. Online ahead of print.
- Incidence trend and disease burden of seven vaccine-preventable diseases in Shandong province, China, 2013-2017: Findings from a population-based observational study. Li ZW, Yin CN, Wang HT, Du WY, Wang WJ, Xue FZ, Zhao L, Cao WC; Cheeloo EcoHealth Consortium (CLEC). Vaccine X. 2022 Feb 5. doi: 10.1016/j.jvacx.2022.100145. eCollection 2022 Apr.
- Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control. Gideon HP, Hughes TK, Tzouanas CN, Wadsworth MH 2nd, Tu AA, Gierahn TM, Peters JM, Hopkins FF, Wei JR, Kummerlowe C, Grant NL, Nargan K, Phuah JY, Borish HJ, Maiello P, White AG, Winchell CG, Nyquist SK, Ganchua SKC, Myers A, Patel KV, Ameel CL, Cochran CT, Ibrahim S, Tomko JA, Frye LJ, Rosenberg JM, Shih A, Chao M, Klein E, Scanga CA, Ordovas-Montanes J, Berger B, Mattila JT, Madansein R, Love JC, Lin PL, Leslie A, Behar SM, Bryson B, Flynn JL, Fortune SM, Shalek AK. Immunity. 2022 Apr 26. doi: 10.1016/j.immuni.2022.04.004. Online ahead of print.